Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002316705 | SCV000850350 | uncertain significance | Inborn genetic diseases | 2016-12-19 | criteria provided, single submitter | clinical testing | The p.G1084S variant (also known as c.3250G>A), located in coding exon 20 of the CACNA1A gene, results from a G to A substitution at nucleotide position 3250. The glycine at codon 1084 is replaced by serine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. |
Labcorp Genetics |
RCV001862067 | SCV002279365 | likely benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2022-03-22 | criteria provided, single submitter | clinical testing |